RAS Pathway Mutations in Juvenile Myelomonocytic Leukemia

Publisher： Karger

E-ISSN： 1421-9662|119|4|207-211

ISSN： 0001-5792

Source： Acta Haematologica, Vol.119, Iss.4, 2008-06, pp. : 207-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild‐type RAS

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 89, Iss. 5, 2014-05 ,pp. : 499-504

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neurofibromatosis Type 1 Diagnosed in a Child Based on Multiple Juvenile Xanthogranulomas and Juvenile Myelomonocytic Leukemia

By  

PEDIATRIC DERMATOLOGY, Vol. 32, Iss. 1, 2015-01 ,pp. : e29-e32

John Wiley & Sons Inc

Access to resources Recommend Favorite

Germline mutation of CBL is associated with moyamoya disease in a child with juvenile myelomonocytic leukemia and Noonan syndrome‐like disorder

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 3, 2015-03 ,pp. : 542-544

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lineage‐dependent skewing of loss of heterozygosity (LOH) of KRAS gene in a case of juvenile myelomonocytic leukemia

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 177-181

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II/III trial of a pre‐transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: A report from the Children's Oncology Group

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 629-636

John Wiley & Sons Inc

Access to resources Recommend Favorite